EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human Group IIA Secreted Phospholipase A2 and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms

Monavvar Andarva, Maria George Elias iD, Mila Sajinovic, Tara Laurine Roberts iD, Paul de Souza, Kieran F Scott iD

International Journal of Molecular Sciences · 14.08.2026 · 27 (16) · 7277

DOI: 10.3390/ijms27167277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.08.2026. Verfasst von Monavvar Andarva und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Prostatic Neoplasms, Group II Phospholipases A2. Die Arbeit nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Western Sydney University, Filamon Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human secreted phospholipase A2 group IIA (hGIIA) is a Ca2+-dependent extracellular enzyme that supports host defense and amplifies inflammation through lipid mediator generation and receptor-linked signaling. In prostate cancer (PCa), hGIIA is commonly elevated compared with benign tissue and can persist after androgen deprivation, implicating it in tumor progression. PCa is typically an immunologically “cold” disease sustained by an immunosuppressive tumor microenvironment enriched in regulatory T cells ( Treg), myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and pro-tumor stromal cells, alongside hypoxia and metabolic rewiring. Because hGIIA is released by innate immune cells and is inducible in macrophages, it is well positioned to strengthen inflammatory lipid networks and promote immune dysfunction within the prostate tumor microenvironment. Here, we review the PCa microenvironment and evaluate evidence linking hGIIA to tumor–stroma crosstalk, angiogenic programming, and therapy resistance, highlighting major knowledge gaps in prostate-focused immune studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentProstatic NeoplasmsGroup II Phospholipases A2HumansMaleAnimals

Stichwörter der Autor:innen

PLA2G2Aimmune modulationprostate cancersecreted phospholipase A2 group IIAtumor microenvironment

Substanzen

Group II Phospholipases A2

Autor:innen und Institutionen

  • School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.
  • Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
  • Nepean Hospital Clinical School, University of Sydney, Kingswood, NSW 2747, Australia.

ORCID-Profile: Maria George Elias, Tara Laurine Roberts, Kieran F Scott

Förderung

  • Western Sydney University
  • Filamon Ltd.

Zitieren

APA

Andarva, M., Elias, M. G., Sajinovic, M., Roberts, T. L., de Souza, P., & Scott, K. F. (2026). Human Group IIA Secreted Phospholipase A2 and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms. International Journal of Molecular Sciences, 27(16), 7277. https://doi.org/10.3390/ijms27167277

Vancouver

Andarva M, Elias MG, Sajinovic M, Roberts TL, de Souza P, Scott KF. Human Group IIA Secreted Phospholipase A2 and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms. International Journal of Molecular Sciences. 2026;27(16):7277. doi:10.3390/ijms27167277

BibTeX
@article{Andarva2026,
  author = {Andarva, Monavvar and Elias, Maria George and Sajinovic, Mila and Roberts, Tara Laurine and de Souza, Paul and Scott, Kieran F},
  title = {Human Group IIA Secreted Phospholipase A2 and the Prostate Cancer Tumor Microenvironment: Potential Mechanisms},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7277},
  doi = {10.3390/ijms27167277}
}
Kostenlos starten →